-
Sekisui XenoTech Introduces Lysosomal Test Systems for Biopharmaceutical Development
Oct 5, 2016, 09:56 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Oct 5, 2016 - Sekisui XenoTech now offers hepatic human lysosomes and rat tritosomes as standard test systems. These products contain high concentrations of lysosomal degradative enzymes and constitute advantageous test systems for analysis of catabolism and/or activation for targeted biopharmaceuticals that enter cells through the endosomal-lysosomal pathwayFull story -
Rumors, Expectations Surround Apple Expansion Into Health Care
Oct 5, 2016, 09:15 AM by Michael CroftPOLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.Full story -
The International Biomedical Research Alliance Appoints Life Sciences Patent Lawyer to its Board
Oct 5, 2016, 08:38 AM by Michael CroftBETHESDA, MD - Oct 5, 2016 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Jeffrey IFull story -
Gene Editing Takes the Stage at Discovery on Target 2016
Oct 5, 2016, 07:00 AM by Michael CroftFull storyBio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.
-
Recipharm launches serialisation showcase line
Oct 5, 2016, 04:22 AM by Michael CroftFONTAINE, FRANCE - Oct 3, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has launched a showcase line for serialisation, offering pharmaceutical companies the chance to view and trial its solution to the new European and US regulationsFull story -
Azure is becoming the first AI supercomputer says Microsoft
Oct 4, 2016, 15:34 PM by Michael CroftZDNet | Microsoft's CEO on how its cloud computing service is evolving.Full story -
Anti-Aging Through Regenerative Medicine
Oct 4, 2016, 14:17 PM by Michael CroftCRYSTAL LAKE, IL, UNITED STATES - Oct 4, 2016 - Treatments utilizing regenerative medicine cause our bodys natural healing processes to work both more effectively and rapidlyFull story -
TARGET PharmaSolutions Announces the Launch of TARGET-PBC (Primary Biliary Cholangitis)
Oct 4, 2016, 12:43 PM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Oct 3, 2016 - TARGET PharmaSolutions, Inc. is pleased to announce the launch of TARGET-PBC (Primary Biliary Cholangitis)Full story -
Biotech PR Needs to Deliver More Signal Less Noise
Oct 4, 2016, 10:49 AM by Michael CroftForbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.Full story -
Genedata Screener 14 Raises the Bar on Efficiency and Workflow Support
Oct 4, 2016, 10:14 AM by Michael CroftBASEL, N/A, SWITZERLAND - Oct 4, 2016 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Screener® version 14Full story -
STERLING PHARMA SOLUTIONS LAUNCHES FOLLOWING MANAGEMENT BUYOUT
Oct 4, 2016, 05:47 AM by Michael CroftDUDLEY, UK - Oct 3, 2016 - UK-based Sterling Pharma Solutions has formed as an independent contract development and manufacturing organisation (CDMO) following a management buyout (MBO) of the UK based Dudley siteFull story -
BARDA Awards Contract to DNAe to Develop Semiconductor DNA Sequencing Platform
Oct 3, 2016, 14:30 PM by Michael CroftFull storyBio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.
-
H1N1 Vaccination Market is Anticipated to Boost in Focus period due to Rising Cases of Swine Flu
Sep 30, 2016, 08:34 AM by Michael CroftALBANY, NY, UNITED STATES - Sep 30, 2016 - H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred as swine fluFull story -
Kidney Function Tests Market Propelled by Increasing Incidence of Kidney Damage
Sep 30, 2016, 06:19 AM by Michael CroftALBANY, NY, UNITED STATES - Sep 30, 2016 - Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the bloodFull story -
High Demand for Radiation-Free Ultrasound to Dominate Ophthalmic Ultrasound System Market’s Future
Sep 30, 2016, 04:19 AM by Michael CroftALBANY, NY, UNITED STATES - Sep 30, 2016 - Ultrasound systems have become as indispensable in the field of ophthalmology as standard clinical assessment modalities such as slit lamp or indirect ophthalmoscopy, the standard means for evaluating the anterior segment of the retinaFull story -
Quertle releases Qinsight — a biomedical literature discovery product built on its BioAI artificial intelligence platform
Sep 29, 2016, 18:35 PM by Michael CroftHENDERSON, NV, UNITED STATES - Sep 29, 2016 - Henderson, Nevada-based Quertle LLC, developer of the first artificial intelligence (AI) biomedical big data platform (BioAI), has released QinsightFull story -
Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits
Sep 29, 2016, 16:35 PM by Michael CroftFull storyBio-IT World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.
-
Oxford Nanopore Announces New Pores, Kits and Updates on Projects
Sep 29, 2016, 13:45 PM by Michael CroftBio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries.Full story -
Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016
Sep 29, 2016, 11:05 AM by Michael CroftBio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.Full story -
SANECA PHARMA INVESTS IN SMALL SCALE API CAPABILITIES
Sep 29, 2016, 10:26 AM by Michael CroftHLOHOVEC, SLOVAKIA - Sep 29, 2016 - CONTRACT development and manufacturing organisation (CDMO) Saneca Pharma is investing heavily in its API capabilities to support client demand for smaller batch sizes and streamlined scale-upFull story